* Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain; and
Departamento de Inmunología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, México
Correspondence: Dr. Francisco Sánchez-Madrid, Servicio de Inmunología, Hospital de la Princesa, Diego de León No. 62, 28006 Madrid, Spain. E-mail: fsanchez{at}hlpr.insalud.es
Leukocyte polarization has a key role in the induction and effector phases of immune response. We assessed the effect of pentoxifylline (PTX) on the polarization and migration of human lymphocytes and neutrophils. A dose-dependent, inhibitory effect on the polarization of lymphoid cells induced by chemokines or IL-15 was found. In addition, PTX interfered with the chemotaxis of peripheral blood T cells and T lymphoblasts. A similar effect was observed on the transendothelial migration of these cells. In addition, the polarization of neutrophils, its adherence to endothelium, and their transendothelial migration, induced by different stimuli, were inhibited by PTX. By contrast, this drug had only a mild effect on endothelial cells and a partial inhibition on the induction of ICAM-1 expression by TNF-
. The inhibitory effect of PTX on leukocyte polarization and extravasation may contribute significantly to the anti-inflammatory and immunoregulatory activity of this drug.
Key Words: T lymphocytes • neutrophils • chemotaxis • chemokines
This article has been cited by other articles:
 |
|
 |
|
  S. Lionaki, K. Siamopoulos, I. Theodorou, E. Papadimitraki, G. Bertsias, D. Boumpas, and J. Boletis Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2144 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Thornhill, L. Baccaglini, E. Theaker, and M. N. Pemberton A Randomized, Double-blind, Placebo-Controlled Trial of Pentoxifylline for the Treatment of Recurrent Aphthous Stomatitis Arch Dermatol, April 1, 2007; 143(4): 463 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Banfi, L. Sironi, G. De Simoni, P. Gelosa, S. Barcella, C. Perego, E. Gianazza, U. Guerrini, E. Tremoli, and L. Mussoni Pentoxifylline Prevents Spontaneous Brain Ischemia in Stroke-Prone Rats J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 890 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dorazil-Dudzik, J. Mika, M. K.- H. Schafer, Y. Li, I. Obara, J. Wordliczek, and B. Przewlocka The Effects of Local Pentoxifylline and Propentofylline Treatment on Formalin-Induced Pain and Tumor Necrosis Factor-{alpha} Messenger RNA Levels in the Inflamed Tissue of the Rat Paw Anesth. Analg., June 1, 2004; 98(6): 1566 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Chen, Y.-Y. Ng, S.-L. Lin, W.-C. Chiang, H. Y. Lan, and T.-J. Tsai Pentoxifylline suppresses renal tumour necrosis factor-{alpha} and ameliorates experimental crescentic glomerulonephritis in rats Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1106 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Layseca-Espinosa, G. Pedraza-Alva, J. L. Montiel, R. del Rio, N. A. Fierro, R. Gonzalez-Amaro, and Y. Rosenstein T cell aggregation induced through CD43: intracellular signals and inhibition by the immunomodulatory drug leflunomide J. Leukoc. Biol., December 1, 2003; 74(6): 1083 - 1093. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Benndorf, R. H. Boger, S. Ergun, A. Steenpass, and T. Wieland Angiotensin II Type 2 Receptor Inhibits Vascular Endothelial Growth Factor-Induced Migration and In Vitro Tube Formation of Human Endothelial Cells Circ. Res., September 5, 2003; 93(5): 438 - 447. [Abstract] [Full Text] [PDF]
|
|
